Strides Pharma Science has completed investment in Strides Consumer Healthcare Business. India Life Sciences Fund III advised by ICP-III Investment Advisors has partnered with Strides and the said transaction has achieved closure on December 20, 2018.
The company had earlier announced about partnering with ICP-III Investment Advisors for funding in its nascent Consumer Healthcare Business.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
